ArticleMayo Clinic proceedings. Digital health2024
Echocardiographic Diagnosis of Hypertrophic Cardiomyopathy by Machine Learning.
Article in Mayo Clinic proceedings. Digital health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- The Evolving Utility of Artificial Intelligence-Based Tools for the Detection of Heart Failure and Cardiomyopathies: From Potential to Implementation.Current heart failure reports · 2026Review
- Clinical Applications of Artificial Intelligence in Cardiovascular Imaging: Where Do We Stand?Life (Basel, Switzerland) · 2026Review
- Artificial intelligence-empowered echocardiography: an updated review of clinical management in hypertrophic cardiomyopathy.Frontiers in cardiovascular medicine · 2026Review
- Artificial Intelligence and Echocardiography: From Literacy to Leadership, Redefining Roles, Responsibilities, and Sustainability in the Artificial Intelligence-driven Echocardiography Era.Journal of cardiovascular echographyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To develop machine learning tools for automated hypertrophic cardiomyopathy (HCM) case recognition from echocardiographic metrics, aiming to identify HCM from standard echocardiographic data with high performance. Patients and Methods: Four different random forest machine learning models were developed using a case-control cohort composed of 5548 patients with HCM and 16,973 controls without HCM, from January 1, 2004, to March 15, 2019. Each patient with HCM was matched to 3 controls by sex, age, and year of echocardiography. Ten-fold crossvalidation was used to train the models to identify HCM. Variables included in the models were demographic characteristics (age, sex, and body surface area) and 16 standard echocardiographic metrics. Results: The models were differentiated by global, average, individual, or no strain measurements. Area under the receiver operating characteristic curves (area under the curve) ranged from 0.92 to 0.98 for the 4 separate models. Area under the curves of model 2 (using left ventricular global longitudinal strain; 0.97; 95% CI, 0.95-0.98), 3 (using averaged strain; 0.96; 95% CI, 0.94-0.97), and 4 (using 17 individual strains per patient; 0.98; 95% CI, 0.97-0.99) had comparable performance. By comparison, model 1 (no strain data; 0.92; 95% CI, 0.90-0.94) had an inferior area under the curve. Conclusion: Machine learning tools that analyze echocardiographic metrics identified HCM cases with high performance. Detection of HCM cases improved when strain data was combined with standard echocardiographic metrics.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.